List of Bulk Drug Substances for Compounding Office Stock Drugs for Use in Nonfood-Producing Animals or Antidotes for Food-Producing Animals; Request for Nominations
Details
The document's own metadata, straight from the source system.
- Title
- List of Bulk Drug Substances for Compounding Office Stock Drugs for Use in Nonfood-Producing Animals or Antidotes for Food-Producing Animals; Request for Nominations
- Posted
- Nov 20, 2019
- Comment period
- Nov 20, 2019 – ?
- FR Doc
- 2019-25140
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Position map
Who stands where on each issue?
Every non-silent position is backed by an excerpt from the comment.
Issues shown
Choose up to five.
| Organization | Compounded medication availability | Compounded metronidazole availability | Stock supply of medications |
|---|
3 organization-typed comments could not be identified.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Aug 24, 2024Comment from AnonymousOtherIndividualRead comment →
- Jun 23, 2024Comment from Alexandra DelfosSupportIndividualRead comment →
- Jun 14, 2024Comment from All Creatures Veterinary Care CenterSupportIndividualRead comment →
- Jun 13, 2024Comment from Dr. Grace ShookOpposeBusiness
A veterinary practice owner argues that the proposed action unfairly restricts the availability of 50mg compounded Metronidazole tablets for office stock. They contend that these tablets are essential for providing immediate care to small patients who cannot take larger doses or oral solutions due to size, side effects, or allergies.
Read comment → - May 30, 2024Comment from Vegas Valley Pet HospitalSupportIndividual
A veterinary professional argues that removing Metronidazole from the list of bulk drug substances for compounding will delay critical treatments for animals with severe infections. They contend that this change will harm patient outcomes, decrease client compliance, and negatively impact the revenue of compounding pharmacies.
Read comment → - May 20, 2024Comment from Sonja FriedbauerOpposeIndividual
Dr. Sonja R. Friedbauer, a veterinarian, argues against removing metronidazole from the list of bulk drug substances for compounding office stock. She states that the drug is essential for treating various conditions in small animals and that requiring compounding could be life-threatening for sick patients.
Read comment → - May 16, 2024Comment from Metro Pet VetSupportIndividualRead comment →
- May 15, 2024Comment from Tina TorresSupportIndividual
The commenter argues that Metronidazole should be included on the list of bulk drug substances for compounding because it is essential for immediate veterinary care. They highlight that delaying treatment for conditions like Giardia can lead to severe animal illness, death, and potential zoonotic transmission to humans.
Read comment → - May 13, 2024Comment from Jennifer TraversSupportIndividual
A veterinarian argues that Metronidazole should remain on the list of office stock drugs for compounding. They state that having small tablets available for immediate use is crucial for treating feline GI issues, as standard tablets are too large and waiting for compounded medications causes delays in care.
Read comment → - May 10, 2024Comment from AnonymousSupportIndividual
A veterinary professional argues that the current list of bulk drug substances for compounding is too restrictive and fails to meet the needs of many patients. They advocate for expanding the list to include more drugs and dosage forms to ensure timely and accurate treatment for animals, particularly those who cannot tolerate commercial products.
Read comment →
